Filter News
Area of Research
- (-) Neutron Science (5)
- (-) Nuclear Science and Technology (1)
- (-) Supercomputing (9)
- Advanced Manufacturing (1)
- Biology and Environment (7)
- Clean Energy (19)
- Computer Science (1)
- Fusion and Fission (3)
- Isotopes (1)
- Materials (19)
- Materials for Computing (2)
- National Security (6)
- Quantum information Science (1)
- Sensors and Controls (1)
News Topics
- (-) Bioenergy (3)
- (-) Biomedical (4)
- (-) Cybersecurity (4)
- (-) Grid (2)
- (-) Materials Science (3)
- (-) Security (3)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (1)
- Biology (3)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (1)
- Composites (1)
- Computer Science (15)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (4)
- Environment (2)
- Exascale Computing (4)
- Frontier (6)
- High-Performance Computing (1)
- Isotopes (1)
- Machine Learning (2)
- Materials (6)
- Microscopy (1)
- Nanotechnology (1)
- National Security (2)
- Neutron Science (14)
- Nuclear Energy (2)
- Partnerships (1)
- Physics (6)
- Quantum Computing (2)
- Quantum Science (6)
- Space Exploration (1)
- Summit (6)
- Sustainable Energy (2)
Media Contacts
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
OAK RIDGE, Tenn., Feb. 12, 2019—A team of researchers from the Department of Energy’s Oak Ridge and Los Alamos National Laboratories has partnered with EPB, a Chattanooga utility and telecommunications company, to demonstrate the effectiveness of metro-scale quantum key distribution (QKD).
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.